References
- SmithRAM’IkanathaNMReadAFAntibiotic resistance: a primer and call to actionHealth Commun201530330931425121990
- VentolaCLThe antibiotic resistance crisis: part 1: causes and threatsP T201540427728325859123
- DaveSBTomaHSKimSJChanges in ocular flora in eyes exposed to ophthalmic antibioticsOphthalmology2013120593794123415422
- GrzybowskiABronaPKimSJMicrobial flora and resistance in ophthalmology: a reviewGraefes Arch Clin Exp Ophthalmol2017255585186228229218
- AzariAABarneyNPConjunctivitis: a systematic review of diagnosis and treatmentJAMA2013310161721172924150468
- BertinoJSJrImpact of antibiotic resistance in the management of ocular infections: the role of current and future antibioticsClin Ophthalmol2009350752119789660
- SharmaSAntibiotic resistance in ocular bacterial pathogensIndian J Med Microbiol201129321822221860100
- AAO PPP Cataract/Anterior Segment Panel, Hoskins Center for Quality Eye CareCataract in the Adult Eye Preferred Practice PatternSan Francisco, CAAmerican Academy of Ophthalmology2016
- AAO PPP Refractive Management/Intervention Panel, Hoskins Center for Quality Eye CareRefractive Errors & Refractive Surgery Preferred Practice PatternSan Francisco, CAAmerican Academy of Ophthalmology2017
- TeweldemedhinMGebreyesusHAtsbahaAHAsgedomSWSaravananMBacterial profile of ocular infections: a systematic reviewBMC Ophthalmol201717121229178851
- KowalskiRPIs antibiotic resistance a problem in the treatment of ophthalmic infections?Expert Rev Ophthalmol201382119126
- ChangVSDhaliwalDKRajuLKowalskiRPAntibiotic resistance in the treatment of Staphylococcus aureus keratitis: a 20-year reviewCornea201534669870325811722
- GentileRCShuklaSShahMMicrobiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year reviewOphthalmology201412181634164224702755
- SchimelAMMillerDFlynnHWJrEndophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven casesAm J Ophthalmol20131561e51:5052
- SleanGRShorsteinNHLiuLPaschalJFWinthropKLHerrintonLJPathogens and antibiotic sensitivities in endophthalmitisClin Exp Ophthalmol201745548148828013528
- KesselLFlesnerPAndresenJErngaardDTendalBHjortdalJAntibiotic prevention of postcataract endophthalmitis: a systematic review and meta-analysisActa Ophthalmol201593430331725779209
- HollandEJMcdonaldMBParekhJGSheppardJDAntibiotic resistance in acute postoperative endophthalmitisOphthalmology201412111 SupplS1S9 quiz S10–1225283879
- ComstockTLPaternoMRUsnerDWPichicheroMEEfficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trialsPaediatr Drugs201012210511220218747
- MorrisTWGearingerLSUsnerDWIntegrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomesClin Ophthalmol201151359136722034555
- ChenFVChangTCCavuotoKMPatient demographic and microbiology trends in bacterial conjunctivitis in childrenJ AAPOS2018221666729247795
- StapletonFCarntNContact lens-related microbial keratitis: how have epidemiology and genetics helped us with pathogenesis and prophylaxisEye (Lond)201226218519322134592
- BrownLResistance to ocular antibiotics: an overviewClin Exp Optom200790425826217535364
- MahFSSanfilippoCMBesifloxacin: efficacy and safety in treatment and prevention of ocular bacterial infectionsOphthalmol Ther20165112027010720
- DeschenesJBlondeauJBesifloxacin in the management of bacterial infections of the ocular surfaceCan J Ophthalmol201550318419126040217
- Global Action Plan on Antimicrobial ResistanceWorld Health Organization2015 Available from: http://www.wpro.who.int/entity/drug_resistance/resources/global_action_plan_eng.pdfAccessed October 10, 2018
- AsbellPAColbyKADengSOcular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolatesAm J Ophthalmol2008145695195818374299
- AsbellPASanfilippoCMAntibiotic resistance trends among ocular pathogens in the US—cumulative results from the antibiotic resistance monitoring in ocular microorganisms (armor) surveillance studyUS Ophthalmic Review20171013538
- AsbellPASanfilippoCMPillarCMDeCoryHHSahmDFMorrisTWAntibiotic resistance among ocular pathogens in the United States: five-year results from the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance studyJAMA Ophthalmol2015133121445145426502312
- HaasWPillarCMTorresMMorrisTWSahmDFMonitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance studyAm J Ophthalmol20111524e563:567574
- Clinical and Laboratory Standards InstituteM07-Ed10. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard-Tenth Edition10th edWayne, PAClinical and Laboratory Standards Institute2015
- Clinical and Laboratory Standards InstituteM100-Ed26. Performance Standards for Antimicrobial Susceptibility Testing26th edWayne, PAClinical and Laboratory Standards Institute2016
- MchughMLMultiple comparison analysis testing in ANOVABiochem Med (Zagreb)201121320320922420233
- ArmitagePTests for linear trends in proportions and frequenciesBiometrics1955113375386
- CochranWGSome methods for strengthening the common χ2 testsBiometrics1954104417451
- MillerDUpdate on the epidemiology and antibiotic resistance of ocular infectionsMiddle East Afr J Ophthalmol2017241304228546690
- OydanichMDingleTCHamulaCLGhisaCAsbellPRetrospective report of antimicrobial susceptibility observed in bacterial pathogens isolated from ocular samples at Mount Sinai Hospital, 2010 to 2015Antimicrob Resist Infect Control2017612928344783
- Besivance® (besifloxacin ophthalmic suspension) 0.6% [prescribing information]Bridgewater, NJBausch & Lomb Incorporated62016
- ChiquetCMaurinMAltayracJCorrelation between clinical data and antibiotic resistance in coagulase-negative Staphylococcus species isolated from 68 patients with acute post-cataract endophthalmitisClin Microbiol Infect2015216592.e1592.e8
- FintelmannREHoskinsENLietmanTMTopical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular culturesArch Ophthalmol2011129439940221482865
- OlsonRDonnenfeldEBucciFAMethicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgeryClin Ophthalmol201041505151421191448
- GarciaADelormeTNasrPPatient age as a factor of antibiotic resistance in methicillin-resistant Staphylococcus aureusJ Med Microbiol201766121782178929116037
- ArkwrightPDDanielTOSanyalDDavidTJPatelLAge-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty centerArch Dermatol2002138793994112071821
- DelormeTRoseSSenitaJCallahanCNasrPEpidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Northeastern OhioAm J Clin Pathol2009132566867719846806
- AdebayoAParikhJGMccormickSAShifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear InfirmaryGraefes Arch Clin Exp Ophthalmol2011249111111920532549
- NiNNamEMHammersmithKMSeasonal, geographic, and antimicrobial resistance patterns in microbial keratitis: 4-year experience in eastern PennsylvaniaCornea201534329630225603231
- PfallerMAMendesREDuncanLRFlammRKSaderHSIn Vitro activities of ceftaroline and comparators against Streptococcus pneumoniae isolates from U.S. Hospitals: results from seven years of the AWARE surveillance program (2010 to 2016)Antimicrob Agents Chemother2018622e015551729158271
- PfallerMAMendesREStreitJMHoganPAFlammRKFive-year summary of in vitro activity and resistance mechanisms of linezolid against clinically important gram-positive cocci in the United States from the LEADER surveillance program (2011 to 2015)Antimicrob Agents Chemother2017617e006091728483950
- SaderHSMendesREStreitJMFlammRKAntimicrobial susceptibility trends among Staphylococcus aureus isolates from U.S. hospitals: results from 7 years of the Ceftaroline (aware) surveillance Program, 2010 to 2016Antimicrob Agents Chemother2017619e010431728630196
- AsbellPAPanditRTSanfilippoCMAntibiotic resistance rates by geographic region among ocular pathogens collected during the ARMOR surveillance studyOphthalmol Ther Epub201889
- KowalskiRPYatesKARomanowskiEGKarenchakLMMahFSGordonYJAn ophthalmologist’s guide to understanding antibiotic susceptibility and minimum inhibitory concentration dataOphthalmology200511211198716183128